Financhill
Buy
52

CLX Quote, Financials, Valuation and Earnings

Last price:
$98.17
Seasonality move :
5.25%
Day range:
$97.11 - $98.33
52-week range:
$96.66 - $164.41
Dividend yield:
5.01%
P/E ratio:
15.39x
P/S ratio:
1.80x
P/B ratio:
41.96x
Volume:
831.6K
Avg. volume:
2.4M
1-year change:
-39.91%
Market cap:
$12B
Revenue:
$7.1B
EPS (TTM):
$6.38

Earnings Data

Next earnings date for CLX
Feb 03
2026
Most recent earnings per share
$0.65
Missed by $0.13
(Nov 3/2025)
Consensus Estimate
$0.78
(Nov 3/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

CLX Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
02/03/2026 Q4 $1.6B -- -- $1.45 --
11/03/2025 Q3 $1.4B $1.4B $0.65 $0.78 -$0.13
07/31/2025 Q2 $1.9B $2B $2.68 $2.21 $0.47
05/05/2025 Q1 $1.7B $1.7B $1.50 $1.56 -$0.06
02/03/2025 Q4 $1.6B $1.7B $1.55 $1.40 $0.15
10/30/2024 Q3 $1.6B $1.8B $0.79 $1.39 -$0.60
08/01/2024 Q2 $1.9B $1.9B $1.73 $1.56 $0.16
04/30/2024 Q1 $1.9B $1.8B -$0.41 $1.37 -$1.78
02/01/2024 Q4 $1.8B $2B $0.75 $1.10 -$0.36
11/01/2023 Q3 $1.3B $1.4B $0.18 -$0.23 $0.41
08/02/2023 Q2 -- $2B $1.42 -- --
05/02/2023 Q1 -- $1.9B -$1.71 -- --
02/02/2023 Q4 -- $1.7B $0.80 -- --
11/01/2022 Q3 -- $1.7B $0.69 -- --
08/03/2022 Q2 -- $1.8B $0.82 -- --
05/02/2022 Q1 -- $1.8B $1.21 -- --
02/03/2022 Q4 -- $1.7B $0.56 -- --
11/01/2021 Q3 -- $1.8B $1.14 -- --
08/03/2021 Q2 -- $1.8B $0.77 -- --
04/30/2021 Q1 -- $1.8B -$0.49 -- --
02/04/2021 Q4 -- $1.8B $2.02 -- --
11/02/2020 Q3 -- $1.9B $3.24 -- --
08/03/2020 Q2 -- $2B $2.41 -- --
05/01/2020 Q1 -- $1.8B $1.89 -- --
02/04/2020 Q4 -- $1.4B $1.46 -- --
10/31/2019 Q3 -- $1.5B $1.59 -- --
08/01/2019 Q2 -- $1.6B $1.88 -- --
05/01/2019 Q1 -- $1.6B $1.44 -- --
02/04/2019 Q4 -- $1.5B $1.40 -- --
10/31/2018 Q3 -- $1.6B $1.62 -- --
08/02/2018 Q2 -- $1.7B $1.65 -- --
05/02/2018 Q1 -- $1.5B $1.37 -- --
02/02/2018 Q4 -- $1.4B $1.77 -- --
11/01/2017 Q3 -- $1.5B $1.46 -- --
08/03/2017 Q2 -- $1.6B $1.52 -- --
05/03/2017 Q1 -- $1.5B $1.31 -- --
02/03/2017 Q4 -- $1.4B $1.14 -- --
11/02/2016 Q3 -- $1.4B $1.35 -- --
08/03/2016 Q2 -- $1.6B $1.25 -- --
05/03/2016 Q1 -- $1.4B $1.23 -- --
02/04/2016 Q4 -- $1.3B $1.13 -- --

The Clorox Co. Earnings Questions

  • How Much did The Clorox Co. Generate in Revenue Last Quarter?

    The Clorox Co. reported $1.4B worth of top line sales in its most recent quarter.

  • Did The Clorox Co. Beat Earnings Last Quarter?

    The Clorox Co. announced earnings per share of $0.65 which represents a miss of analyst forecast a $0.78 per share.

  • Is The Clorox Co. Profitable?

    The Clorox Co. reported $594M that represents $4.83 per share over the last quarter.

  • What is the Analyst Consensus for The Clorox Co. EPS Next Year?

    The Clorox Co.'s earnings are forecast to decrease from $6.52 per share to $7.06 per share next year representing a decrease of -8.21%.

  • When is The Clorox Co.'s Earnings Date?

    The Clorox Co.'s next earnings date is February 3, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is DocuSign Stock Undervalued?
Is DocuSign Stock Undervalued?

Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…

Is SentinelOne Stock Undervalued?
Is SentinelOne Stock Undervalued?

Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…

Is Broadcom Stock on Sale?
Is Broadcom Stock on Sale?

Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…

Stock Ideas

Buy
57
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 64x

Buy
55
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 37x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
80
TVTX alert for Dec 25

Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.

Buy
68
KOD alert for Dec 25

Kodiak Sciences, Inc. [KOD] is up 13.41% over the past day.

Buy
64
ZCSH alert for Dec 25

Grayscale Zcash Trust (ZEC) [ZCSH] is up 5.33% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock